Logo image of FCLI.CA

FULL CIRCLE LITHIUM CORP (FCLI.CA) Stock Fundamental Analysis

TSX-V:FCLI - TSX Venture Exchange - CA3599171012 - Common Stock - Currency: CAD

0.385  0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FCLI. FCLI was compared to 14 industry peers in the Electrical Equipment industry. FCLI has a great financial health rating, but its profitability evaluates not so good. FCLI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FCLI has reported negative net income.
FCLI had a negative operating cash flow in the past year.
FCLI.CA Yearly Net Income VS EBIT VS OCF VS FCFFCLI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -1M -2M -3M -4M -5M

1.2 Ratios

FCLI has a better Return On Assets (-55.06%) than 61.54% of its industry peers.
Looking at the Return On Equity, with a value of -59.59%, FCLI is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
Industry RankSector Rank
ROA -55.06%
ROE -59.59%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FCLI.CA Yearly ROA, ROE, ROICFCLI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 -20 -40 -60

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FCLI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FCLI.CA Yearly Profit, Operating, Gross MarginsFCLI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

8

2. Health

2.1 Basic Checks

FCLI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, FCLI has an improved debt to assets ratio.
FCLI.CA Yearly Shares OutstandingFCLI.CA Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 20M 40M 60M
FCLI.CA Yearly Total Debt VS Total AssetsFCLI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 21.98 indicates that FCLI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 21.98, FCLI belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
FCLI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 21.98
ROIC/WACCN/A
WACCN/A
FCLI.CA Yearly LT Debt VS Equity VS FCFFCLI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 0 2M -2M 4M -4M 6M

2.3 Liquidity

A Current Ratio of 2.00 indicates that FCLI should not have too much problems paying its short term obligations.
The Current ratio of FCLI (2.00) is better than 84.62% of its industry peers.
FCLI has a Quick Ratio of 1.99. This is a normal value and indicates that FCLI is financially healthy and should not expect problems in meeting its short term obligations.
FCLI has a better Quick ratio (1.99) than 84.62% of its industry peers.
Industry RankSector Rank
Current Ratio 2
Quick Ratio 1.99
FCLI.CA Yearly Current Assets VS Current LiabilitesFCLI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 1M 2M 3M

3

3. Growth

3.1 Past

The earnings per share for FCLI have decreased strongly by -1406.93% in the last year.
EPS 1Y (TTM)-1406.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.39%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 51.49% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 198.45% on average over the next years. This is a very strong growth
EPS Next Y-47.67%
EPS Next 2Y41.42%
EPS Next 3Y51.49%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y243.73%
Revenue Next 3Y198.45%
Revenue Next 5YN/A

3.3 Evolution

FCLI.CA Yearly Revenue VS EstimatesFCLI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 5M 10M 15M
FCLI.CA Yearly EPS VS EstimatesFCLI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.02 -0.02 0.04 -0.04 0.06 -0.06

1

4. Valuation

4.1 Price/Earnings Ratio

FCLI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FCLI.CA Price Earnings VS Forward Price EarningsFCLI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FCLI.CA Per share dataFCLI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 -0.1

4.3 Compensation for Growth

FCLI's earnings are expected to grow with 51.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y51.49%

0

5. Dividend

5.1 Amount

No dividends for FCLI!.
Industry RankSector Rank
Dividend Yield N/A

FULL CIRCLE LITHIUM CORP

TSX-V:FCLI (2/21/2025, 7:00:00 PM)

0.385

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)02-04 2025-02-04
Earnings (Next)N/A N/A
Inst Owners5.7%
Inst Owner ChangeN/A
Ins Owners20.6%
Ins Owner ChangeN/A
Market Cap28.72M
Analysts84
Price Target1.53 (297.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.99%
Min EPS beat(2)0.99%
Max EPS beat(2)0.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-50%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-100%
EPS NY rev (3m)-100%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2024.94
P/FCF N/A
P/OCF N/A
P/B 3.4
P/tB 3.45
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.06%
ROE -59.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1852.7%
Cap/Sales 29322.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2
Quick Ratio 1.99
Altman-Z 21.98
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1406.93%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.39%
EPS Next Y-47.67%
EPS Next 2Y41.42%
EPS Next 3Y51.49%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y243.73%
Revenue Next 3Y198.45%
Revenue Next 5YN/A
EBIT growth 1Y-1061.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.2%
EBIT Next 3Y58.42%
EBIT Next 5YN/A
FCF growth 1Y-359.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4708.63%
OCF growth 3YN/A
OCF growth 5YN/A